AdaptHealth Corp.
Reads like this one publish minutes after the filing lands on EDGAR. Get them as JSON over the API or inside your AI agent over MCP.
No SEC Form 4 filings for $AHCO in the last 30 days.
See all $AHCO insider activity →BrightSpring Health Services (down 15.1%) and AdaptHealth (down 44.4%) reported Q2 earnings, with the latter missing revenue and EBITDA guidance. Addus HomeCare was up 1.1%, while Brookdale (down 27.7%) had the slowest revenue growth. AdaptHealth's stock trades at $6.02, Addus at $118.04, and Brookdale at $9.90.
AdaptHealth (AHCO) shares fell 8.6% after announcing Harriss T. Currie as CFO, replacing Jason Clemens. The company reported a Q2 loss of $0.99 per share, missing estimates, and cut 2026 revenue guidance to $2.87B. The stock is down 41.6% YTD and 57.8% from its 52-week high.
AdaptHealth Corp. (AHCO) filed an SEC Form 8-K — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers. Exhibit 99.1 ADAPTHEALTH CORP. FOR IMMEDIATE RELEASE AdaptHealth Appoints Harriss Currie as Chief Financial Officer PLYMOUTH MEETING, Pa. – September 8th 2026 - AdaptHealth Corp. (NASDAQ: AHCO) (“AdaptHealth” or the “Company”) , a national leader in providing patient-centered, he
Over the past 7 days, AlphAI's AI scored 1 news story mentioning AHCO (AdaptHealth Corp.). Coverage has skewed bearish: 0 bullish, 0 neutral, and 1 bearish.
Recent AHCO coverage spans earnings, corporate actions and financial news.
Disappointing results and weak guidance likely pressure the stock.
The CFO appointment triggered a sharp sell‑off, indicating investor concern over leadership continuity.
CFO transition is a near-term governance and execution signal, but the filing provides no financial targets or guidance changes.
The settlement may lead to a modest negative impact on AdaptHealth's share price due to legal expense and reputational risk.
Weak revenue growth and missed guidance cause sharp sell‑off.
AlphAI scores every news story that mentions AHCO with an AI model for sentiment and relevance, and aggregates insider trades from AdaptHealth Corp.'s SEC EDGAR Form 4 filings. Figures refresh continuously.
BrightSpring Health Services (down 15.1%) and AdaptHealth (down 44.4%) reported Q2 earnings, with the latter missing revenue and EBITDA guidance. Addus HomeCare was up 1.1%, while Brookdale (down 27.7%) had the slowest revenue growth. AdaptHealth's stock trades at $6.02, Addus at $118.04, and Brookdale at $9.90.
3 min readAdaptHealth (AHCO) shares fell 8.6% after announcing Harriss T. Currie as CFO, replacing Jason Clemens. The company reported a Q2 loss of $0.99 per share, missing estimates, and cut 2026 revenue guidance to $2.87B. The stock is down 41.6% YTD and 57.8% from its 52-week high.
2 min readAdaptHealth Corp. (AHCO) filed an SEC Form 8-K — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers. Exhibit 99.1 ADAPTHEALTH CORP. FOR IMMEDIATE RELEASE AdaptHealth Appoints Harriss Currie as Chief Financial Officer PLYMOUTH MEETING, Pa. – September 8th 2026 - AdaptHealth Corp. (NASDAQ: AHCO) (“AdaptHealth” or the “Company”) , a national leader in providing patient-centered, he
3 min readA North Carolina federal court preliminarily approved a $14.3M settlement for AdaptHealth Corp. regarding overbilling claims for returned medical equipment.
1 min readMcKesson (MCK) fell 9.1% post-earnings despite a solid quarter. AdaptHealth (AHCO) missed revenue and EBITDA estimates, down 46.2%. Elevance Health (ELV) beat revenue and EPS estimates but lost customers, down 7.4%. Quest (DGX) topped expectations, up 12.6%.
3 min readAdaptHealth Corp. (AHCO) cut its 2026 adjusted EBITDA outlook to $490 million to $520 million from $680 million to $730 million, citing margin pressure from West Coast capitated contract costs and a manufacturer price increase. Revenue guidance is $2.85 billion to $2.89 billion. Q2 organic revenue rose 15.9% to $740.3 million. The company agreed to sell Diabetes Health for $235 million.
6 min readU.S. indexes drifted lower as crude oil and interest rates were mostly flat, with investors awaiting the July CPI report. FactSet data for 88% of S&P 500 firms showed 86% positive earnings surprises and 76% positive revenue surprises. Nasdaq fell 0.6% to 26,445, S&P 500 0.3% to 7,728, Dow 0.3% to 53,791. CoreWeave (CRWV) and Super Micro (SMCI) report after the close; Nvidia (NVDA) and Intel (INTC) were also discussed.
6 min readAdaptHealth (AHCO) reported Q2 2026 net revenue of $740.3 million, up 12.7% year over year, with organic revenue growth of 15.9%. Adjusted EBITDA was $132 million, down 3.2%, and full-year revenue guidance was cut to $2.85-$2.89 billion with adjusted EBITDA of $490-$520 million. The company cited West Coast contract costs and a $30 million supplier price headwind, plus a $235 million diabetes divestiture.
7 min readAdaptHealth (NASDAQ:AHCO) said it will sell its diabetes unit to focus on sleep and respiratory. The deal is expected to leave about $60 million of overhead costs in continuing operations, with roughly half removed in year one. Q2 revenue grew 16%, including West Coast expansion, while the company works on contract onboarding and supplier rebate terms.
6 min readAdaptHealth Corp. (NASDAQ:AHCO) director Kenneth A. Samet bought 23,500 shares on Aug. 6, 2026 at $6.38 each for about $149,930. After the purchase, he beneficially owns 48,569 shares. The stock is near its 52-week low. The company recently reported a Q2 adjusted loss of $0.99 vs a $0.15 expected profit, with revenue of $740.3 million.
3 min read
